| Financial Year |
March 31 2023 |
| Monetary Funds |
4,466,007,813.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
500,000.00 |
| Accounts Receivable |
1,347,844,948.98 |
| Advances to Suppliers |
112,738,070.01 |
| Other Receivables |
78,074,119.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
44,864,616.22 |
| Inventories |
172,561,290.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
131,071,678.55 |
| Total Current Assets |
6,630,019,427.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,309,687,792.42 |
| Investment Properties |
652,287,870.40 |
| Fixed Assetes |
15,715,241,941.09 |
| Under-construction Projects |
888,895,583.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,070,372,545.34 |
| R&D expenses |
-- |
| Goodwill |
33,862,271.04 |
| Long-Term Deferred and Prepaid Expenses |
6,265,445.52 |
| Deferred Income Tax Assets |
123,065,631.66 |
| Other Non-Current Assets |
114,200,000.00 |
| Sub-Total of Non-Current Assets |
27,711,816,643.94 |
| Total Assets |
34,341,836,071.60 |
| Short-Term Loans |
640,046,666.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
92,301,786.40 |
| Accounts Payable |
1,512,895,405.92 |
| Accounts Received In Advance |
500,122,779.74 |
| Employee Compensation Payable |
152,698,258.38 |
| Taxes Payable |
128,472,093.09 |
| Interest Payable |
-- |
| Dividend Payable |
364,937,048.93 |
| Other payables |
483,008,333.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,105,346,007.20 |
| Other Current Liabilities |
32,497,883.95 |
| Sub-Total of Current Liabilities |
4,962,862,697.78 |
| Long-term Loans |
3,854,510,454.77 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
205,098,876.93 |
| Other Non-Current Liabilities |
478,157.63 |
| Sub-Total of Non-Current Liabilities |
4,268,142,944.21 |
| Total Liabilities |
9,231,005,641.99 |
| Paid-In Capital(Or Share Stock) |
2,894,001,038.00 |
| Capital Surplus |
2,951,457,440.86 |
| Surplus Reserve |
2,661,879,183.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,598,917,365.58 |
| Minority Stockholder's Interest |
6,870,464,563.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,240,365,865.69 |
| Owner's Equity（Stockholder's Equity） |
25,110,830,429.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
34,341,836,071.60 |
